Sharda Cropchem Ltd Q2 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/i162fl9mfr462kt4bny7swoq.pdf

Key Takeaways


Volume, Mix & the Pricing Puzzle

Bubna: "Mr. Rajdeep, you have touched the right point, and it is actually the product mix, which didn't occur to me, and this has occurred to you."

The Registration Moat & Tariff Immunity

Bubna: "Every company who has the registration of that product in that country can bid for the tender. But there are not many people who have such a wide range of registrations and the registration process is a very complicated, investment-oriented, time-consuming and boring."

Agrochemical vs Non-Agrochemical Divergence

SegmentRevenue (Q2 FY26)YoY GrowthDriver
Agrochemical₹803 cr▲ 27%Volume recovery across regions, slow price uptrend
Non-agrochemical₹126 cr▼ 11%Demand variation; lower volume, no consistency expected

Margin Bridge & the H2 Bet


Capex, Revenue Ambition & the Non-Speculation Stance

Bubna: "We don't speculate. We take opinions of the experts, and we find that many times the experts also go wrong. They are not fortune tellers."

Deflections & Unanswered Questions


Guidance & Commitments

CommitmentSpecificsTimeline
Full-year EBITDA margin15% to 18%FY26
Full-year capex₹450 cr to ₹500 crFY26
H2 vs H1 seasonalitySecond half stronger than first halfFY26
H2 gross marginsIn similar range to H1H2 FY26
US tariff impactNo substantial impact expectedH2 FY26
Revenue crossing ₹5,000 crConfirmed as possibleFY26

Key Metrics

MetricQ2 FY26
Revenue₹929 cr, +20% YoY
Agrochemical revenue₹803 cr, +27% YoY
Non-agrochemical revenue₹126 cr, -11% YoY
Overall volume growth35% YoY
Agrochemical volume growth36% YoY
Gross margin34.5%, +690 bps YoY
EBITDA₹139 cr, +71% YoY
EBITDA margin15%
PAT₹74 cr, +75% YoY
FY26 EBITDA margin guidance15% to 18% for full year
Working capital days84 days, improvement of 34 days vs March 2025
Cash, bank and liquid investments₹794 cr as on 30 September 2025
Total product registrations2,994 as on 30 September 2025
Registration applications at approval stage1,068 globally
ROCE21.6% as on 30 September 2025
ROE17.5% as on 30 September 2025